Technology
3rd Pharma Meets AI Conference
Join pharma leaders and AI innovators in Barcelona for the 3rd Pharma Meets AI Conference. Discover trends and shape the future of Pharma.
21Speakers
0Sponsors
23On the bill · sessions
16Companies · in total
Speakers
Programmed at 3rd, in alphabetical order.Alex Turpin
Head AI Governance R&D · AstraZeneca
Beatriz Roson
Director, Bioinformatics - Predictive AI & Data · AstraZeneca
Beatriz Rosón
Director, Bioinformatics - Predictive AI & Data
Carlos Amat
Executive Manager · SDG Group
Debarshi Dey
Vice President, Head of Biometrics · Galapagos
Dorota Herman
Associate Director, AI/ML in Drug Discovery · Johnson & Johnson Innovative Medicine
Dr. Judith Koliwer
Senior Industry Advisor and Principal Consultant Advanced Therapies · Körber Pharma Software
Elliott Parris
Advanced Data Solutions Manager, EMEA · Elsevier
Filipe Diniz
Director, Global Strategy Execution & Change Catalyst · MSD
Filip Rais
Director of Technical Architecture - Artificial Intelligence & Data and Analytics · MSD
Florent Hassen
Global Product Owner - AI and Omnichannel Advanced Analytics · Roche
Francesco Pogliano
PhD, Lead Software Engineer · Expert Analytics
Frank Seo
CCO · Medisights
Jiajie Zhang
Chief Data Science and AI Officer · Evinova
Jordi Casanellas
Director of AI · Bayer
Jordi Escayola
Global Head Advanced Analytics, Artificial Intelligence & Data Science (Senior Director) · Opella
Kathrin Hahn
Head Data Privacy, Digital and AI Region Europe (CIPPE) · Novartis
Natasha Hansjee
Everyday AI Champion · Roche
Pablo Chirosa Lara
Senior Commercial Director AI enabled Clinical Development · Evinova
Sam Rolfe
Sales Director, EMEA · Exeevo
Sebastian Sbirna
Data Governance Lead – Global Data & AI · Novo Nordisk
Agenda
Selected from 23 sessions on the bill.- 09:10 AM
Designing Trust at Scale: AI Governance as an Innovation Enabler in Pharma
AI governance in the pharmaceutical industry is often perceived as a necessary constraint: a compliance-driven layer added once AI systems are already in motion. In practice, this …
- 09:50 AM
Leveraging Harmonised Data and Measurable Results for Successful AI Projects in Field Medical & Commercial
As HCP demographics and expectations continue to change, this session explores how you can leverage clean, harmonised data sources to provide meaningful inputs and drive measurable…
- 10:00 AM
Faster Precision Medicine and Advanced Analysis with Cytofit
Precision medicine increasingly relies on mass cytometry to characterize the immune system at single-cell resolution, but its clinical impact remains limited by slow and inefficien…
- 10:15 AM
Omics Based Safety Predictions
Omics-based safety predictions harness multi-omics data—genomics, transcriptomics, proteomics, and cellular imaging to anticipate adverse effects of drug candidates early in develo…
- 11:00 AM
Humanizing AI: How Leaders Bring People, Agents, and Automation Together for Real Adoption
Drawing on more than 15 years of executive leadership at the intersection of technology and business operations, Filipe approaches AI‑driven transformation with a people‑first mind…
- 11:25 AM
Holistic by Design: A best practice approach for AI enablement in personalized Cell & Gene Therapies
Autologous cell and gene therapies hold tremendous potential for patients, but at the same time place unprecedented demands on understanding and optimizing the manufacturing proces…
- 11:40 AM
AI in Drug Development: From Hype to Decisions — What It Takes to Make It Work
Despite decades of innovation and billions invested, nearly 90% of drugs still fail in clinical development. Artificial Intelligence promises to change this — from improving target…
- 11:40 AM
Real Case Studies From Top Pharma On How Evinova AI Authoring Is Redefining Workflows For Clinical Study Teams And Delivering Tangible $ Benefits At Scale
During this session Dr Jiajie Zhang and Pablo Chirosa will share with real examples and demos how you redesign clinical development workflows for authoring documents such as CSPs a…
- 12:20 PM
Harnessing large-scale data and thoughtful data strategies in drug discovery
In the complex and data-intensive realm of drug discovery, the importance of thoughtful data generation cannot be overstated. Strategic data collection is fundamental to transformi…
Intermission
Part the Second · For the Buyer
An audience of 16 companies, parsed from the program.
Sixteen companies in attendance.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.
0All threespeak · spons · exh
0Sponsoringsponsor only
16Companies Speakingspeaker only
57% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.
- C-suite15%
- Founder / Owner15%
- VP-level15%
- Director / Head of943%
- Manager / Lead419%
- Advisor / Investor15%
- Other roles419%
Of 21 on the bill · classified by free-text title
- 01AstraZeneca2V
- 02Evinova2V
- 03MSD2V
- 04Roche2V
- 05Bayer1V
- 06Elsevier1V
- 07Exeevo1V
- 08Expert Analytics1V
- 09Galapagos1V
- 10Johnson & Johnson Innovative Medicine1V
- 11Körber Pharma Software1V
- 12Medisights1V
- 13Novartis1V
- 14Novo Nordisk1V
Tiers were not disclosed for this event.